Across Europe , the use of ketamine for psychiatric conditions is seeing a significant rise. Primarily employed as an anesthetic, ketamine's utility as a therapy for depression , particularly treatment-resistant forms, has sparked considerable interest among healthcare providers. While regulations vary considerably from nation to nation , the gr